Jack with an EBITDA of just 6.5 million off 100 million which is a 6.5% return which could easily be devasted by currency movements alone.
This companies overheads are too high in a space of high capex requirements and I can understand why people are steering clear
100 million for a poultry 6.5 leaves almost no margin for error.
- Forums
- ASX - By Stock
- QHL
- Financial Half Year Results
Financial Half Year Results, page-6
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add QHL (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $28.33M |
Open | High | Low | Value | Volume |
39.5¢ | 40.0¢ | 39.5¢ | $26.28K | 65.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 82757 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 5335 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 82757 | 0.395 |
1 | 200000 | 0.390 |
3 | 138250 | 0.385 |
1 | 39473 | 0.380 |
5 | 285523 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 4015 | 1 |
0.405 | 148427 | 5 |
0.410 | 166244 | 8 |
0.415 | 28238 | 2 |
0.420 | 30053 | 5 |
Last trade - 10.40am 12/11/2024 (20 minute delay) ? |
Featured News
QHL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online